Pentoxifylline attenuates LPS-induced bronchial hyperresponsiveness but not the increase in exhaled nitric oxide

Clinical and Experimental Allergy

Volumn 27, Issue 1, 1997, Pages 96-103

  Rolla, G ^a   Bucca, C ^a   Brussino, L ^a   Dutto, L ^a   Colagrande, P ^a   Polizzi, S ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bronchial hyperresponsiveness; Lipopolysaccharide; Nitric oxide; Pentoxifylline

Indexed keywords

LIPOPOLYSACCHARIDE; METHACHOLINE; NITRIC OXIDE; PENTOXIFYLLINE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL;

ADULT; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESCHERICHIA COLI; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; METHACHOLINE CHLORIDE; NITRIC OXIDE; PEAK EXPIRATORY FLOW RATE; PENTOXIFYLLINE; VASODILATOR AGENTS;

EID: 0031018156     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb00678.x     Document Type: Article

References (45)

1. Pernis B, Vigliani EC, Cavagna C, Finulli M. The role of bacterial endotoxins in occupational diseases caused by inhaling vegetable dusts. Br J Ind Med 1961; 18:120-9.
2. Castellan RM, Olenchock SA, Kinsley KB, Hankinson JL. Inhaled endotoxin and decreased spirometric values. N Engl J Med 1987; 317:605-0.
3. Thedell TD, Mull JC, Olenchock SA. A brief report of gram-negative bacterial endotoxin levels in airborne and settled dusts in animal confinement buildings. Am J Ind Med 1980; 1:3-7.
4. Pratt DS, May JJ. Feed-associated respiratory illness in farmers. Arch Environ Health 1984; 39:43-8.
5. Cavagna G, Foa V, Vigliani EC. Effects in man and rabbits of inhalation of cotton dust or extracts and purified endotoxins. Br J Ind Med 1969; 26:314-321.
6. Jamison JP, Lowry RC. Bronchial challenge of normal subjects with endotoxin of Enterobacter agglomerans isolated from cotton dust. Br J Ind Med 1986; 43:327-31.
7. Rylander R, Bake B, Fischer JJ, Helander IM. Pulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 1989; 140:981-6.
8. Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989; 66:1059-64.
9. Van der Zwan JC, Orie NGM, Kauffman HF, Wiers PWJ, De Vries K. Bronchial obstructive reactions after inhalation with endotoxin and precipitinogenes of Haemophilus influenzae in patients with chronic non-specific lung disease. Clin Allergy 1982; 12:547-59.
10. Michel O, Ginanni R, Sergysels R. Relation between the bronchial obstructive response to inhaled lipopolysaccharide and bronchial responsiveness to histamine. Thorax 1992; 47:288-91.
11. Chang SW, Feddersen CO, Henson PM, Voelkel NF. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 1987; 79:1498-1509.
12. Cook JA, Wise WC, Halushua PV. Elevated tromboxane levels in the rat during endotoxin shock. J Clin Invest 1980; 65:227-30.
13. Dinarello CA. Interleukin-1. Rev Infect Dis 1984; 6:51-95.
14. Michie HR, Manogue KR, Spriggs DR et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-86.
15. Kips JC, Tavernier J, Pawels RA. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992; 145:332-6.
16. Thomas PS, Yates DH, Barnes PJ. Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995; 152:76-80.
17. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide:physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42.
18. Thiemermann C, Wu CC, Szabo C, Perretti M, Vane JR. Role of tumor necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharmacol 1993; 110:177-82.
19. Stewart TE, Valenza F, Ribeiro SP, Wener AD, Volgyesi G, Mullen JBM, Slutsky AS. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med 1995; 151:713-18.
20. Schroer RH. Antithrombotic potential of pentoxifylline, a hemorheologically active drug.Angiology 1985; 36:387-92.
21. Welsh CH, Lieu D, Worthen GS, Weil JV. Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog. Am Rev Respir Dis 1988; 138:1106-14.
22. Ishizaka A, Wu Z, Stephens KE et al. Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. Am Rev Respir Dis 1988; 138:376-82.
23. Lilly CM, Sandhu JS, Ishizaka A, et al. Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis 1989; 139:1361-8.
24. Zabel P, Wolter DT, Schonharting MM, Schade UF. Oxpentifylline in endotoxaemia. Lancet 1989; ii:1474-7.
25. Noel P, Nelson S, Bobulic R. Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci 1990; 47:1028-33.
26. Alegre M, Gastaldello K, Abramowicz D et al. Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation 1991; 52:674-9.
27. Kharitonov SA, Yates D, Robbins RA et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-5.
28. American Thoracic Society Executive Committee. Recommended standardized procedures for pulmonary function testing. Am Rev Respir Dis 1978; 118 (Part 2):55-62.
29. Quanjer PH. Standardized lung function testing. Bull Eur Physiopathol Respir 1983; 19 (Suppl. 5):1-91.
30. Chai H, Farr RS, Froehlich LA et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323-7.
31. Vandivier RW, Eidsath A, Godin P et al. Exhaled nitric oxide in volunteers administered sodium nitroprusside or endotoxin. Am J Respir Crit Care Med 1995; 151:713-8.
32. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995; 151:1894-9.
33. De Monchy JGR, Kauffman HP, Venge P et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131:373-6.
34. Gordon T, Balmes J, Fine J, Sheppard D. Airway oedema and obstruction in guinea pigs exposed to inhaled endotoxin. Br J Ind Med 1991; 48:629-5.
35. Pawels RA, Kips JC, Peleman RA, Van Der Straeten ME. The effect of endotoxin inhalation on airway responsiveness and cellular influx in rats. Am Rev Respir Dis 1990; 141:540-5.
36. Haas F, Bevelacqua F, Levin N et al. Pentoxifylline improves pulmonary gas exchange. Chest 1990; 97:621-627.
37. Kips JC, Lefebvre RA, Peleman RA, Joos GF, Pauwels RA. The effect of a nitric oxide synthase inhibitor on the modulation of airway responsiveness in rats. Am J Respir Crit Care Med 1995; 151:1165-9.
38. Dupuy PM, Shore AS, Drazen JM et al. Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992; 90:421-8.
39. Torphy TJ, Undem BJ. Phosphodiesterase inhibitors:new opportunities for the treatment of asthma. Thorax 1991; 46:512-23.
40. Taflet SM, Singhel KJ, Overholtzer JF, Shurtleff SA. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell Immunol 1989; 120:291-300.
41. Spatafora M, Chiappara G, Merendino AM et al. Theophylline suppresses the release of tumor necrosis factor-α by blood monocytes and alveolar macrophages. Eur Respir J 1994; 7:223-8.
42. Raeburn D, Karlsson JA. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea-pig airways. J Pharmacol Exp Ther 1993; 267:1147-52.
43. Moodley I, Mottin G, Perrin, Junien JL, Lagente V. Effects of selective phosphodiesterase inhibitors and theophylline on antigen-induced microvascular leakage in the guinea-pig trachea (abstract). Am J Respir Crit Care Med 1994; 149:A328.
44. Johnston CA, Greisman SE. Mechanisms of endotoxin tolerance. In: Hinshaw LB, ed. Handbook of endotoxins. Volume 2: Pathophysiology of endotoxin. Amsterdam: Elsevier 1985: 359-401.
45. Michel O, Ginanni R, Duchateau J et al. Domestic endotoxin exposure and clinical severity of asthma. Clin Exp Allergy 1991; 21:441-8.